Dr Lalchandani Labs Ltd - 541299 - Closure of Trading Window
closure of Trading window28-06-2024
Dr Lalchandani Labs Ltd - 541299 - Board Meeting Outcome for Audited Standalone Financial Statement Of The Company For The Half Year And Year Ended March 2024
Audited standalone Financial results of the Company for the Financial year ended March 202430-05-2024
Dr Lalchandani Labs Ltd - 541299 - Audited Standalone Financial Statements Of The Company For The Half Year And Year Ended March 2024
Audited standalone financial statements of the Company for the half year and year ended March 202430-05-2024
Dr Lalchandani Labs Ltd - 541299 - Board Meeting Intimation for Consideration Of Audited Financial Statement For The Half Year And Year Ended March 31, 2024
Dr Lalchandani Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 ,inter alia, to consider and approve Approval of Financial statement for the year ended March 31, 202418-05-2024
Dr Lalchandani Labs Ltd - 541299 - Appointment of Company Secretary and Compliance Officer
Appointment of Ms. Namita Anand as Company Secretary and Compliance officer of the Company02-05-2024
Dr Lalchandani Labs Ltd - 541299 - Compliance Certificate Under Regulation 40(10) Of SEBI (LODR) Regulations, 2015
compliance certificate under Reg 40(10) for the quarter ended March 202420-04-2024
Dr Lalchandani Labs Ltd - 541299 - Compliance Certificate Under Regulation 7(3) Of SEBI (LODR) Regulations For The Year Ended March 2024
Compliance Certificate for the year ended March 202417-04-2024
Dr Lalchandani Labs Ltd - 541299 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate by RTA under Reg 74(5) for the quarter ended March, 202415-04-2024
Dr Lalchandani Labs Ltd - 541299 - Reply To The Clarification Sought Dated April 09, 2024
Reply to the clarification sought10-04-2024